BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14675239)

  • 1. Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease?
    Dolan K; Morris AI; Gosney JR; Field JK; Sutton R
    J Gastroenterol Hepatol; 2004 Jan; 19(1):24-30. PubMed ID: 14675239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction.
    van de Ven C; De Leyn P; Coosemans W; Van Raemdonck D; Lerut T
    Eur J Cardiothorac Surg; 1999 Jun; 15(6):769-73. PubMed ID: 10431857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative histochemical evaluation of mucins expression in fetal esophagus and adenocarcinomas of the gastroesophageal junction.
    Vernygorodskyi S; Rekun T; Zhuchenko P
    Exp Oncol; 2018 Oct; 40(3):223-227. PubMed ID: 30285012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
    van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
    Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of upper gastrointestinal malignancies.
    Sarbia M; Becker KF; Höfler H
    Semin Oncol; 2004 Aug; 31(4):465-75. PubMed ID: 15297939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal
    Adeshuko FA; Squires MH; Poultsides G; Pawlik TM; Weber SM; Schmidt C; Votanopoulos K; Fields RC; Maithel SK; Cardona K
    Am Surg; 2017 Jan; 83(1):82-89. PubMed ID: 28234131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gastro-oesophageal junction carcinomas in Chinese versus American patients.
    Huang Q; Fan X; Agoston AT; Feng A; Yu H; Lauwers G; Zhang L; Odze RD
    Histopathology; 2011 Aug; 59(2):188-97. PubMed ID: 21884197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinomas of the distal esophagus and "gastric cardia" are predominantly esophageal carcinomas.
    Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T
    Am J Surg Pathol; 2007 Apr; 31(4):569-75. PubMed ID: 17414104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology.
    Dolan K; Sutton R; Walker SJ; Morris AI; Campbell F; Williams EM
    Br J Cancer; 1999 May; 80(5-6):834-42. PubMed ID: 10360663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction.
    Polkowski W; van Sandick JW; Offerhaus GJ; ten Kate FJ; Mulder J; Obertop H; van Lanschot JJ
    Ann Surg Oncol; 1999; 6(3):290-7. PubMed ID: 10340889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
    Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
    Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
    El Jabbour T; Misyura M; Cowzer D; Zimmermann M; Rimkunas V; Marra A; Derakhshan F; Selenica P; Parilla M; Setton JS; Ceyhan-Birsoy O; Kemel Y; Catchings A; Ranganathan M; Ku GY; Janjigian YY; Zinda M; Koehler M; Stadler Z; Shia J; Reis-Filho JS; Mandelker D
    J Natl Cancer Inst; 2022 May; 114(5):761-770. PubMed ID: 35078243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma.
    Gao XS; Qiao X; Wu F; Cao L; Meng X; Dong Z; Wang X; Gao G; Wu TT; Komaki R; Chang JY
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):389-96. PubMed ID: 17236963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance and prognostic value of lysosomal enzyme activities measured in surgically operated adenocarcinomas of the gastroesophageal junction and squamous cell carcinomas of the lower third of esophagus.
    Altorjay A; Paal B; Sohar N; Kiss J; Szanto I; Sohar I
    World J Gastroenterol; 2005 Oct; 11(37):5751-6. PubMed ID: 16270380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma of the cardia: classification as esophageal or gastric cancer?
    von Rahden BH; Feith M; Stein HJ
    Int J Colorectal Dis; 2005 Mar; 20(2):89-93. PubMed ID: 15688098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia.
    Marsman WA; Birjmohun RS; van Rees BP; Caspers E; Johan G; Offerhaus A; Bosma PJ; Jan J; van Lanschot B
    Clin Cancer Res; 2004 Dec; 10(24):8479-85. PubMed ID: 15623628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.
    Lerut T; Nafteux P; Moons J; Coosemans W; Decker G; De Leyn P; Van Raemdonck D; Ectors N
    Ann Surg; 2004 Dec; 240(6):962-72; discussion 972-4. PubMed ID: 15570202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma of the GEJ: gastric or oesophageal cancer?
    Rüschoff J
    Recent Results Cancer Res; 2012; 196():107-13. PubMed ID: 23129369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas.
    van Duin M; van Marion R; Vissers KJ; Hop WC; Dinjens WN; Tilanus HW; Siersema PD; van Dekken H
    Cytogenet Genome Res; 2007; 118(2-4):130-7. PubMed ID: 18000363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer?
    Gertler R; Stein HJ; Loos M; Langer R; Friess H; Feith M
    Am J Surg Pathol; 2011 Oct; 35(10):1512-22. PubMed ID: 21934477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.